Showing results (21-30 of 143) with videos related to
Sort By:
Pageof 15
Diabetologia|July 2, 2010
Do insulinotropic glucose-lowering drugs do more harm than good? The hypersecretion hypothesis revisitedI Rustenbeck, S Baltrusch, M TiedgeAmerican Journal of Physiology. Endocrinology and Metabolism|May 28, 2009
Plasma membrane depolarization as a determinant of the first phase of insulin secretionK Hatlapatka, M Willenborg, I RustenbeckBiochemical Pharmacology|January 5, 2002
Desensitization of insulin secretory response to imidazolines, tolbutamide, and quinine. I. Secretory and morphological studiesI Rustenbeck, M Winkler, A JörnsBiochemical Pharmacology|January 5, 2002
Desensitization of insulin secretory response to imidazolines, tolbutamide, and quinine. II. Electrophysiological and fluorimetric studiesI Rustenbeck, C Dickel, T GrimmsmannsDiabetologia|November 12, 2005
Essential role of the imidazoline moiety in the insulinotropic effect but not the KATP channel-blocking effect of imidazolines; a comparison of the effects of efaroxan and its imidazole analogue, KU14RC Bleck, A Wienbergen, I RustenbeckDiabetes|August 1, 1997
Energetic requirement of insulin secretion distal to calcium influxI Rustenbeck, C Herrmann, T GrimmsmannEndokrinologie|January 1, 1976
The effect of hydrocortisone treatment and adrenalectomy on insulin and glucagon secretion from the perfused rat pancreasS LenzenDiabetologia|December 19, 2007
The mechanisms of alloxan- and streptozotocin-induced diabetesS LenzenThe American Journal of Physiology|April 1, 1979
Insulin secretion by isolated perfused rat and mouse pancreasS LenzenMetabolism: Clinical and Experimental|January 1, 1978
Dose-response studies on the inhibitory effect of thyroid hormones on insulin secretion in the ratS LenzenPageof 15